Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany). Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach. 1178
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013
Prediction of exercise capacity using impulse oscillation system in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015
Exercise related desaturation in patients with COPD – Another step towards phenotyping the disease Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
COPD patients with exertional desaturation have a higher risk of rapid lung function decline Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009
Physical activity (PA) levels during recovery from severe acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease Year: 2014
The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016
Fluctuations in airway function: chronic asthma seen as a complex dynamic system Source: Annual Congress 2006 - Physiological year in review Year: 2006
Cardio-metabolic profile, function and physical activity in mild-moderate COPD patients Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015
Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015
The influence of hyperinflation on body composition and cytokine profile in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
The Evaluation of nutritional status of stable COPD patients and to investigate the effect of nutritional status on perception of dyspnea, exercise capacity, body composition, hospitalisation and life quality Source: International Congress 2014 – Clinical presentations Year: 2014
Evaluation of nutritional status, disease severity and anxiety/depression in COPD patients with different exercise capacity Source: International Congress 2016 – Monitoring comorbidities Year: 2016
Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016